CD4 and heterotaxy, visceral, 5, autosomal: First, MCM 38141 received daily antiretroviral therapy for a portion of the study, which suppressed SIV viremia and restored CD4+ T cell count, and thus perhaps this macaque did not achieve the necessary degree of immunosuppression to trigger uncontrolled LCV+ B cell proliferation and lymphomagenesis.